Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (391-400 of 494) with videos related to

Pageof 50
Sort By:
Plos One|December 5, 2015
Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeJane W Marsh, Mary G Krauland, Jemma S Nelson, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2016
Comment on: Resistance gene naming and numbering: is it a new gene or not?George A Jacoby, Robert A Bonomo, Patricia A Bradford, et al.
BMC Emergency Medicine|August 31, 2017
Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infectionDavid T Huang, Derek C Angus, Chung-Chou H Chang, et al.
Mbio|September 12, 2023
Daily fosfomycin versus levofloxacin for complicated urinary tract infectionsNadine Rouphael, Patricia Winokur, Michael C Keefer, et al.
ESC Heart Failure|September 23, 2021
Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremiaTatsufumi Oka, Takayuki Hamano, Tomohito Ohtani, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.
Jac-Antimicrobial Resistance|September 10, 2024
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> infectionsRyan K Shields, Ava J Dorazio, Giusy Tiseo, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2014
CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?Christa Ewers, Astrid Bethe, Ivonne Stamm, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2015
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysisPatrick N A Harris, Jane Y Wei, Andrew W Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2021
Utility and Applicability of Rapid Diagnostic Testing in Antimicrobial Stewardship in the Asia-Pacific Region: A Delphi ConsensusAnucha Apisarnthanarak, Hong Bin Kim, Luke S P Moore, et al.
Pageof 50

Showing results (391-400 of 494) with videos related to

Sort By:
Pageof 50
Plos One|December 5, 2015
Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeJane W Marsh, Mary G Krauland, Jemma S Nelson, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2016
Comment on: Resistance gene naming and numbering: is it a new gene or not?George A Jacoby, Robert A Bonomo, Patricia A Bradford, et al.
BMC Emergency Medicine|August 31, 2017
Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infectionDavid T Huang, Derek C Angus, Chung-Chou H Chang, et al.
Mbio|September 12, 2023
Daily fosfomycin versus levofloxacin for complicated urinary tract infectionsNadine Rouphael, Patricia Winokur, Michael C Keefer, et al.
ESC Heart Failure|September 23, 2021
Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremiaTatsufumi Oka, Takayuki Hamano, Tomohito Ohtani, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.
Jac-Antimicrobial Resistance|September 10, 2024
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> infectionsRyan K Shields, Ava J Dorazio, Giusy Tiseo, et al.
The Journal of Antimicrobial Chemotherapy|January 9, 2014
CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?Christa Ewers, Astrid Bethe, Ivonne Stamm, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2015
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysisPatrick N A Harris, Jane Y Wei, Andrew W Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2021
Utility and Applicability of Rapid Diagnostic Testing in Antimicrobial Stewardship in the Asia-Pacific Region: A Delphi ConsensusAnucha Apisarnthanarak, Hong Bin Kim, Luke S P Moore, et al.
Pageof 50